Series C Completed
Umoja Biopharma Series C
US$100m raised
Announced 14 Jan 2025
Investors
Led by
- DCVC · Co-lead
- Double Point Ventures · Co-lead
With
- ARK Invest
- Cormorant Asset Management
- MPM Capital
- Qiming Venture Partners
- RTW Investments
- Alexandria Ventures
- CaaS Capital
- Yosemite
- K 12 Health Ventures
- Myeloma Investment Fund
- University of Minnesota Endowment Fund
Investors as the sources name them; a linked name has a FundComb profile.
- Company
- Umoja Biopharma
- Stage
- Series C
- Amount raised
- US$100m
- Company based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, Oncology
Similar rounds
- Ayar Labs Series D Dec 2024 · US$155m · led by Advent Global Opportunities
- Radiant Industries Series C Nov 2024 · US$100m · led by DCVC
- Lumafield Series C Mar 2025 · US$75m
- Decagon Series C Jun 2025 · US$131m · led by Accel
- True Anomaly Series C Apr 2025 · US$260m · led by Accel
Sources
- 14 Jan 2025 Manufacturing cancer-killing T cells inside the body dcvc.com